The 3D-Printed Ordered Bredigite Scaffold Promotes Pro-Healing of Critical-Sized Bone Defects by Regulating Macrophage Polarization
DOI: https://doi.org/10.2147/IJN.S393080
IF: 7.033
2023-02-21
International Journal of Nanomedicine
Abstract:Yaowei Xuan, 1, &ast Lin Li, 2, &ast Chenping Zhang, 3, 4 Min Zhang, 1 Junkai Cao, 1 Zhen Zhang 3, 4 1 Department of Stomatology, The First Medical Centre, Chinese PLA General Hospital, Beijing, People's Republic of China; 2 State Key Laboratory of Military Stomatology & National Clinical Research Center for Oral Diseases & Shaanxi Clinical Research Center for Oral Diseases, Department of Periodontology, School of Stomatology, Fourth Military Medical University, Xi'an, People's Republic of China; 3 Department of Oral Maxillofacial-Head Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China; 4 College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhen Zhang; Junkai Cao, Tel/Fax +86 153-1779-7335 ; +86 139-0129-0992, Email ; Background: Repairing critical-sized bone defects secondary to traumatic or tumorous damage is a complex conundrum in clinical practice; in this case, artificial scaffolds exhibited preferable outcomes. Bredigite (BRT, Ca 7 MgSi 4 O 16 ) bioceramic possesses excellent physicochemical properties and biological activity as a promising candidate for bone tissue engineering. Methods: Structurally ordered BRT (BRT-O) scaffolds were fabricated by a three-dimensional (3D) printing technique, and the random BRT (BRT-R) scaffolds and clinically available β-tricalcium phosphate (β-TCP) scaffolds were compared as control groups. Their physicochemical properties were characterized, and RAW 264.7 cells, bone marrow mesenchymal stem cells (BMSCs), and rat cranial critical-sized bone defect models were utilized for evaluating macrophage polarization and bone regeneration. Results: The BRT-O scaffolds exhibited regular morphology and homogeneous porosity. In addition, the BRT-O scaffolds released higher concentrations of ionic products based on coordinated biodegradability than the β-TCP scaffolds. In vitro, the BRT-O scaffolds facilitated RWA264.7 cells polarization to pro-healing M2 macrophage phenotype, whereas the BRT-R and β-TCP scaffolds stimulated more pro-inflammatory M1-type macrophages. A conditioned medium derived from macrophages seeding on the BRT-O scaffolds notably promoted the osteogenic lineage differentiation of BMSCs in vitro. The cell migration ability of BMSCs was significantly enhanced under the BRT-O-induced immune microenvironment. Moreover, in rat cranial critical-sized bone defect models, the BRT-O scaffolds group promoted new bone formation with a higher proportion of M2-type macrophage infiltration and expression of osteogenesis-related markers. Therefore, in vivo, BRT-O scaffolds play immunomodulatory roles in promoting critical-sized bone defects by enhancing the polarization of M2 macrophages. Conclusion: 3D-printed BRT-O scaffolds can be a promising option for bone tissue engineering, at least partly through macrophage polarization and osteoimmunomodulation. Graphical Keywords: bredigite, three-dimensional printing, osteoimmunomodulation, macrophage polarization, tissue engineering Graphical The limited regenerative potential of endogenous bone repair in critical-sized defects remains a substantial clinical challenge. Along with the advancement of tissue engineering technology, biomaterial scaffolds have gradually shown advantages over autologous bone grafts by overcoming their limitations as a new clinical strategy. 1–3 However, currently available scaffold biomaterials have deficiencies in complex bone regeneration applications, such as mismatched structural support, uncoordinated biodegradability and lack of osteoinductivity. 4,5 To overcome these shortcomings, recent cutting-edge biomaterials have been explored for bone tissue engineering. 6,7 Considering their bioactive nature, magnesium-containing silicate bioceramics have been investigated as promising candidates for bone tissue engineering. 8 Bredigite (BRT, Ca 7 MgSi 4 O 16 ) contains various bioactive elements including calcium (Ca), magnesium (Mg), and silicon (Si). 9–11 Previous studies have demonstrated that BRT bioceramics possessed excellent biocompatibility, apatite-mineralization ability, and mechanical properties. 10−12 Furthermore, by releasing a variety of ionic products, BRT bioceramics may r -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology